MPs urge government to set out plans for post-Brexit medicines regulation MPs have urged the government to set out its plans for regulatory functions currently delivered by the EU, including those relating to medicines safety, as soon as possible.…
Preserving research and development in a post-Brexit era Additional funding for R&D post-Brexit is a welcome move from the UK government, but there are other related issues to consider as well.…
Government delays over Brexit having ‘corrosive effect’ on science R&D, say Lords Government delays in addressing the impact of Brexit on the UK’s science community is having a “corrosive effect” on research and development that could damage the economy in the long run, according to the findings of an inquiry by peers in the House of Lords.…
The Pharmaceutical Journal’s most read opinion pieces of 2016A round up of the most popular opinion pieces of 2016.…
EU drug spending fell after 2008 recession Report finds fall in pharmaceutical spending since financial crisis and disparity in public medicines coverage across EU.…
‘Hard Brexit’ could delay access to new drugs, think tank warns A ‘hard Brexit’ could threaten the success of the UK life sciences industry and restrict access to new medicines, a think tank has warned.…
What is the Falsified Medicines Directive? Aileen Bryson, practice and policy lead at RPS Scotland, speaks to Julia Robinson about the purpose of the Falsified Medicines Directive and how it will affect pharmacists in the UK.…
New treatment option for Parkinson’s disease launched in the UK Drug company BIAL Pharm UK has launched opicapone (Ongentys), a new drug to improve mobility in some adult patients with Parkinson’s disease, for use in the UK. …
European conditional approval given for rare liver disease drug The European Medicine Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended a new drug to treat a rare and potentially lethal liver disease for conditional marketing approval across the EU. Obeticholic acid (Ocaliva; Intercept Pharma) has been re…
The history of antibiotic use in livestock and its contribution to antimicrobial resistance ‘One health and the politics of antimicrobial resistance’, by Laura Kahn.…